Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility
- PMID: 23171454
- DOI: 10.1111/exd.12049
Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility
Abstract
NACHT leucine-rich repeat- and PYD-containing (NLRP)3 protein controls the inflammasome by regulating caspase-1 activity and interleukin (IL)-1β processing. The contribution of IL-1β in the pathogenesis of psoriasis is well recognized. Polymorphisms in NLRP3 and caspase recruitment domain-containing protein (CARD)8, a negative regulator of caspase-1 activity, have been associated with susceptibility to common inflammatory diseases, such as Crohn's disease and rheumatoid arthritis. To investigate the role for genetic variants in the NLRP3 inflammasome in psoriasis susceptibility. In a patient sample comprising 1988 individuals from 491 families and 1002 healthy controls, genotypes for four selected single-nucleotide polymorphisms (SNPs) in NLRP3 (three SNPs) and CARD8 (one SNP) were determined by TaqMan(®) Allelic Discrimination. Using the transmission disequilibrium test (TDT), a significant increase in the transmission of the NLRP3 rs10733113G genotype to a subgroup of patients with more widespread psoriasis was demonstrated (P = 0.015). Using logistic regression analysis in 741 patients with psoriasis and 1002 controls, the CARD8 rs2043211 genotype was significantly different in cases and controls in overall terms [OR 1.3 (1.1-1.5), P = 0.004] and for both genders. Our data support the hypothesis that the inflammasome plays a role in psoriasis susceptibility.
© 2012 John Wiley & Sons A/S.
Similar articles
-
Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis.Scand J Rheumatol. 2013;42(6):465-8. doi: 10.3109/03009742.2013.779020. Epub 2013 Apr 2. Scand J Rheumatol. 2013. PMID: 23547871
-
Association study of CARD8 (p.C10X) and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French and Tunisian populations.Int J Immunogenet. 2012 Apr;39(2):131-6. doi: 10.1111/j.1744-313X.2011.01070.x. Epub 2011 Dec 1. Int J Immunogenet. 2012. PMID: 22128899
-
Genetic Polymorphisms in Inflammasome-Dependent Innate Immunity among Pediatric Patients with Severe Renal Parenchymal Infections.PLoS One. 2015 Oct 7;10(10):e0140128. doi: 10.1371/journal.pone.0140128. eCollection 2015. PLoS One. 2015. PMID: 26444566 Free PMC article.
-
Role of genetic alterations in the NLRP3 and CARD8 genes in health and disease.Mediators Inflamm. 2015;2015:846782. doi: 10.1155/2015/846782. Epub 2015 Feb 18. Mediators Inflamm. 2015. PMID: 25788762 Free PMC article. Review.
-
NLRP3 p.Q705K and CARD8 p.C10X single nucleotide polymorphisms are not associated with susceptibility to rheumatoid arthritis: a meta-analysis.Int J Rheum Dis. 2017 Oct;20(10):1481-1491. doi: 10.1111/1756-185X.13016. Epub 2017 Feb 9. Int J Rheum Dis. 2017. PMID: 28185410 Review.
Cited by
-
Psoriasis: An Immunogenetic Perspective.Glob Med Genet. 2022 Jun 13;9(2):82-89. doi: 10.1055/s-0042-1743259. eCollection 2022 Jun. Glob Med Genet. 2022. PMID: 35707771 Free PMC article. Review.
-
Natural Product-Derived Compounds Targeting Keratinocytes and Molecular Pathways in Psoriasis Therapeutics.Int J Mol Sci. 2024 May 31;25(11):6068. doi: 10.3390/ijms25116068. Int J Mol Sci. 2024. PMID: 38892253 Free PMC article. Review.
-
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.Arch Pharm Res. 2021 Jan;44(1):16-35. doi: 10.1007/s12272-021-01307-9. Epub 2021 Feb 3. Arch Pharm Res. 2021. PMID: 33534121 Free PMC article. Review.
-
Electrophiles Against (Skin) Diseases: More Than Nrf2.Biomolecules. 2020 Feb 11;10(2):271. doi: 10.3390/biom10020271. Biomolecules. 2020. PMID: 32053878 Free PMC article. Review.
-
Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis.Int J Mol Sci. 2021 Aug 31;22(17):9449. doi: 10.3390/ijms22179449. Int J Mol Sci. 2021. PMID: 34502368 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical